Arvee Laboratories (India) Ltd.

ARVEE

INE006Z01016

Diversified Chemicals

Market Closed - NSE India S.E. Other stock markets 12:32:26 18/05/2024 pm IST			5-day change	1st Jan Change
183.7 ^INR	-1.92%		-7.57%	+6.22%

26/03	Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director	CI
13/02	Arvee Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director

March 26, 2024 at 01:28 pm IST

Arvee Laboratories (India) Ltd. informed that Mr. Dipen Dalal, - Independent Director of the company has tendered his resignation vide letter dated March 26, 2024. He will be cease to be a Director of the company with effect from 26th March, 2024.

Latest news about Arvee Laboratories (India) Ltd.

Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director	26/03	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	07/11	CI
Arvee Laboratories Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	05/23/05	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	11/22/11	CI
Arvee Laboratories Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2022	02/22/02	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	26/22/26	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022	26/22/26	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	08/22/08	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/21/12	CI
Arvee Laboratories Ltd. Announces Demise of Parag Manubhai Shah, Independent Director	17/21/17	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2021	17/21/17	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	17/21/17	CI
1,130,000 Equity Shares of Arvee Laboratories Limited are subject to a Lock-Up Agreement Ending on 27-FEB-2021.	27/21/27	CI
Arvee Laboratories Ltd. Appoints Neetu Jalan as a Non-Executive Independent Director	12/21/12	CI
Arvee Laboratories Ltd. Announces Unaudited Earnings Results for the Half Year Ended September 30, 2020	07/20/07	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the Full Year Ended March 31, 2020	29/20/29	CI
Arvee Laboratories Ltd. Approves Appointment of Mr. Paragbhai Manubhai Shah as Independent Director	27/20/27	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the Half Year Ended September 30, 2019	14/19/14	CI
2,920,000 Equity Shares of Arvee Laboratories Limited are subject to a Lock-Up Agreement Ending on 27-FEB-2019.	27/19/27	CI
Arvee Laboratories Limited has completed an IPO in the amount of INR 89.06 million.	21/18/21	CI
Arvee Laboratories Limited has filed an IPO in the amount of INR 89.06 million.	21/17/21	CI

Chart Arvee Laboratories (India) Ltd.

Duration

Period

More charts

Company Profile

Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.

Sector

Diversified Chemicals

Calendar

30/07/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diversified Chemicals

	1st Jan change	Capi.
ARVEE LABORATORIES (INDIA) LTD.	+6.22%	24.78M
SHIN-ETSU CHEMICAL CO., LTD.	-1.30%	75B
BASF SE	+0.19%	47.43B
DUPONT DE NEMOURS, INC.	+3.87%	33.41B
PIDILITE INDUSTRIES LIMITED	+11.03%	18.24B
EASTMAN CHEMICAL COMPANY	+11.76%	11.8B
SYENSQO SA/NV	+1.70%	10.97B
BRENNTAG SE	-16.29%	10.93B
ASAHI KASEI CORPORATION	-0.10%	9.26B
SRF LIMITED	-8.12%	8.11B

Diversified Chemicals

Arvee Laboratories (India) Ltd.

Equities

ARVEE

INE006Z01016

Diversified Chemicals

Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director

Latest news about Arvee Laboratories (India) Ltd.

Chart Arvee Laboratories (India) Ltd.

Company Profile

Income Statement Evolution

Sector Diversified Chemicals